Highlights the critical need to recognize and apply gender-specific symptomatology and risk factors to improve cardiovascular disease management and outcomes in women.
Prompts clinicians to apply gender-related CVD risk factors; leaves open whether systematic use narrows outcome disparities in women.
Cardiovascular disease (CVD) in women remains under-diagnosed and undertreated due to the diagnostic challenge it presents, as well as the persisting attitude that CVD predominantly affects men. Gender-related risk factors have now been identified but there is a lack of clinical application, leading to the misdiagnosis and poor management of women with CVD. It is necessary to address gender-specific symptomatology and risk factors in order to optimise management and positively influence morbidity and mortality in this cohort of patients.
No takes yet. Share an insight, caveat, or question.
Keteepe‐Arachi et al. (2017) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: